SMS Pharmaceuticals
SMSPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Ramesh Babu · MD: Ramesh Babu · Listing date: Feb. 28, 2007 · Employees: 1080 · Hyderabad · http://www.smspharma.com

Stock Price vs Company Growth
1d
4.5%
1w
8.6%
1m
17.7%
3m
32.7%
6m
19.3%
1y
103.2%
5y
43.4%
10y
19.1%
all
12.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 240 4.5%
234
398
Company Overview

Sales
768 Cr
Growth: 25.6%
Profit after Tax
59.3 Cr
Growth: 4.2%
Small Cap
2,030 Cr
P/E: 34.2x
Industry P/E: 35.6x
Fundamentals

Sales (Cr) ₹ 768
Growth 25.6%
EBITDA 16.6%
P/S 2.6x
Dividend 0.2%
P/E 34.2x
Book Value ₹ 67
PEG Ratio 1.3x
ROE 11.0%
P/B 3.6x
Shareholding Pattern

Institutions
Venkata Subbaraju Penmatsa .
2.13 %
Vivek Mundra
1.23 %
Aniruddh Mundra
1.13 %
Madhusudan Murlidhar Kela
1.1 %
Iepf
0.07 %
Promoters
Ramesh Babu Potluri
18.37 %
Hima Bindu Potluri
17.47 %
Vamsi Krishna Potluri
15.74 %
Potluri Infra Projects Llp
8.68 %
Trilok Potluri
2.58 %
Others
Increase    Decrease    No change
Company Profile Detailed

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi location group having product list spreading across an array of therapeutic segments. SMS is currently a listed company having ever appreciating international and domestic customer base.
Investors (45)